LIPUM AB

Behind the Scenes with Eva-Lotta Andersson: ”As a laboratory engineer at Lipum, my colleague Kajsa and I are responsible for analyzing incoming samples while actively advancing our research and development efforts. It’s incredibly exciting to be part of this journey, which began as a research project in Medical Chemistry and has now grown into something much larger. The work is both challenging and varied – no day is like the other, which makes it both inspiring and enjoyable to come to work every day.” 

Kom ihåg! Imorgon, fredag den 25 oktober, bjuder G&W Fondkommission in Lipum till en presentation av kvartalsrapport och bolagets nuvarande status. Presentationen startar kl. 09:00. Registrera dig här: https://lnkd.in/dsNTqHW4 Senare, kl. 10:00, kommer VD Ola Sandborgh att kommentera kvartalsrapporten för juli-september 2024 i en webcast via Finwire. Se sändningen här: https://lnkd.in/dCwm8V76 Välkommen! #lipum #gwfondkommission #finwire #kvartalsrapport #q3 #lifescience

Behind the Scenes with Kajsa Linde: "My role as a laboratory engineer involves not only analyzing and documenting experimental work in the lab but also actively participating in the planning, management, and setup of various experiments. What excites me the most about my job is the variety of tasks. I am constantly given the opportunity to learn new things, take on challenges, and solve complex problems. What inspires me the most is knowing that what we do can make a difference for people in the future. Working at a smaller company like Lipum means being more involved in decision-making, which gives me a greater ability to influence my work, something I see as very positive. I also experience a strong sense of teamwork at Lipum".

På fredag den 25 oktober bjuder G&W Fondkommission in Lipum till en presentation av kvartalsrapport och bolagets nuvarande status. Presentationen startar kl. 09:00. Registrera dig här: https://lnkd.in/dsNTqHW4 Senare, kl. 10:00, kommer VD Ola Sandborgh att kommentera kvartalsrapporten för juli-september 2024 i en webcast via Finwire. Se sändningen här: https://lnkd.in/dCwm8V76  Välkommen!  #lipum #gwfondkommission #finwire #kvartalsrapport #q3 #lifescience

- We are pleased with the successful collaboration with Karolinska Institutet. The research team’s work on BSSL is promising and could lead to more effective treatments for inflammatory diseases, says CEO Ola Sandborgh. Read BioStock's interview with the project leader, Associate Professor Bence Rethi, Karolinska Institutet. #lipum #biostock #karolinskainstitutet #lifescience

Lipums vd Ola Sandborgh gästar Västra Hamnens studio och blir intervjuad av chefsanalytiker Martin Dominique om Lipums projekt, potential och planer. #lipum #läkemedelsutveckling #antikropp #reumatoidartrit

Save the date: On November 4-6, Ola Sandborgh and Peter Hovstadius will participate at Bio-Europe 2024 in Stockholm. Welcome to meet them and learn more about Lipums first-in-class anti-BSSL antibody SOL-116 and the phase I study results.  Register here: https://lnkd.in/dFZ7BBx  #lipum #bioeurope #biotech #lifescience 

CEO Ola Sandborgh comments on the BioStock - Connecting Innovation and Capital´s article: "It is very gratifying that we have reached this point in the development program and that, with this, we will be able to receive a final report within a few months." #lipum #biostock #phase1 #sol_116 #drugdevelopment

"It is very satisfying that all healthy subjects and patients are now included in the phase 1 study. It is an important milestone and I look forward to the final report that will provide us with valuable information for the next step in clinical development," says Lipum's CEO Ola Sandborgh. #lipum #phase1 #drugdevelopment #sol_116

A reminder that on September 18-19, Lipum's Ola Sandborgh will participate in the Nordic Life Science Days in Malmö to share and discuss Lipum's progress and results from the clinical phase 1 study, as well as presenting plans and key milestones to investors and partners. #lipum #nlsdays #investormeeting #lifescience